• Publications
  • Influence
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
Chronic neuropathic pain, caused by lesions in the peripheral or central nervous system, comes in many forms. We describe current approaches to the diagnosis and assessment of neuropathic pain andExpand
  • 1,184
  • 53
  • PDF
Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.
UNLABELLED Patients with advanced cancer who have pain that responds poorly to opioid therapy pose a clinical challenge. Nabiximols (Nabiximols is the U.S. Adopted Name [USAN] for Sativex [GW PharmaExpand
  • 206
  • 13
  • PDF
Adult cancer pain.
Pain is a common symptom associated with cancer and its treatment. Pain management is an important aspect of oncologic care, and unrelieved pain significantly comprises overall quality of life. TheseExpand
  • 236
  • 10
Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study
Controlled‐release oral formulations of oxycodone and morphine are both suitable analgesics for moderate to severe pain. They were compared in cancer‐pain patients randomized to double‐blindExpand
  • 171
  • 6
  • PDF
NCCN Practice Guidelines for Cancer Pain.
The overall approach to pain management encompassed in these guidelines is comprehensive. It is based on objective pain assessments, utilizes both pharmacologic and nonpharmacologic interventions,Expand
  • 138
  • 4
Physicians' Attitudes Toward Pain and the Use of Opioid Analgesics: Results of a Survey from the Texas Cancer Pain Initiative
Background. Despite extensive progress in the scientific understanding of pain in humans, serious mismanagement and undermedication in treating acute and chronic pain is a continuing problem. ThisExpand
  • 185
  • 3
NCCN clinical practice guidelines in oncology: palliative care.
  • 149
  • 3
Fentanyl pectin nasal spray in breakthrough cancer pain.
Abstract Fentanyl pectin nasal spray (FPNS) is being developed to improve analgesic onset, treatment efficacy, and satisfaction/acceptability in treating breakthrough cancer pain (BTCP). Patients (nExpand
  • 23
  • 3
Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates.
OBJECTIVES (1) To assess the feasibility and tolerability of the therapeutic transdermal fentanyl system (TTS-fentanyl) by using a clinical protocol developed for children with cancer pain. (2) ToExpand
  • 79
  • 2
Medical Students' Attitudes Toward Pain and the Use of Opioid Analgesics: Implications for Changing Medical School Curriculum
Background. Barriers to pain management include physicians' lack of knowledge and attitudes. Our aim was to investigate future physicians' knowledge and attitudes toward pain and the use of opioidExpand
  • 99
  • 2